Literature DB >> 1872016

Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.

B Christenson1, M Böttiger.   

Abstract

A two-dose vaccination programme using a combined measles, mumps and rubella vaccine (MMR) and administration at the ages of 18 months and 12 years was introduced in 1982. The 12-year-old schoolchildren were tested yearly from 1985 to 1989 on serum samples obtained prior to and after vaccination. Each year between 420 and 756 children were tested. The method used for antibody testing was the haemolysis-in-gel (HIG) assay. For measles also the enzyme-linked immunosorbent assay (ELISA) and the neutralization titre (NT) were applied. Only minor variations of the prevaccination immunity to measles were seen during the period 3-7 years after introduction of the programme. The age groups studied had partly been vaccinated against measles earlier. Between 12 and 16% lacked prevaccination immunity. In contrast the immunity to mumps and rubella of the 12-year-old children decreased considerably during the study period. No general vaccination against these diseases had been performed. Thus the susceptibility to mumps increased from 14% in 1985 to 39% in 1989 and to rubella from 41 to 57%. The seroconversion rate of children seronegative for measles was high, i.e. 100% in 1985 and later varied between 96 and 97%. For mumps, the seroconversion rate was lower and varied between 72 and 88%. All sera converted to rubella. During the follow-up period there was a declining incidence of measles, mumps and rubella. The relationship between the vaccination and reduction of disease and natural immunity strongly suggests that the association is causal and that this vaccination policy reduced the transmission of infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1872016     DOI: 10.1016/0264-410x(91)90058-e

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination strategy.

Authors:  C Zotti; O Ossola; R Barberis; A Castella; A M Ruggenini
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

2.  Measles, mumps, rubella (MMR) vaccine.

Authors:  A P Dubey; S Banerjee
Journal:  Indian J Pediatr       Date:  2003-07       Impact factor: 1.967

3.  Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.

Authors:  Rania A Tohme; Jeannot François; Kathleen Wannemuehler; Roc Magloire; M Carolina Danovaro-Holliday; Brendan Flannery; Kathleen F Cavallaro; David L Fitter; Nora Purcell; Amber Dismer; Jordan W Tappero; John F Vertefeuille; Terri B Hyde
Journal:  Trop Med Int Health       Date:  2014-07-16       Impact factor: 2.622

4.  Rubella antibody levels in school-aged children in Newfoundland: Implications for a two-dose rubella vaccination strategy.

Authors:  S Ratnam; R West; V Gadag; B Williams; E Oates
Journal:  Can J Infect Dis       Date:  1997-03

5.  A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

Authors:  Cecilia Ahlgren; Kjell Torén; Anders Odén; Oluf Andersen
Journal:  Eur J Epidemiol       Date:  2009-07-26       Impact factor: 8.082

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.